Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5025-5034

  Pendergrast, P Shannon ^a,b   Morrison, Debra ^b,c   Tansey, William P ^b   Hernandez, Nouria ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TATA BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; RNA SYNTHESIS;

EID: 0029946308     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5025-5034.1996     Document Type: Article

References (56)

1. Berkhout, B., and K.-T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
2. Carey, M., H. Kakidani, J. Leatherwood, F. Mostashari, and M. Ptashne. 1989. An amino terminal fragment of GALA4 binds as a dimer. J. Mol. Biol. 209:423-432.
3. Chen, J.-L., L. D. Attardi, P. C. Vrreijzer, K. Yokomori, and R. Tjian. 1994. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79:93-105.
4. Cullen, B. R. 1993. Does HIV-1 tat induce a change in viral initiation rights. Cell 73:417-420.
5. Das, G., C. S. Hinkley, and W. Herr. 1995. Basal promoter elements as a selective determinant of transcriptional activator function. Nature (London) 374:657-660.
6. Dynlacht, B. D., T. Hoey, and R. Tjian. 1991. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 66:563-576.
7. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4949.
8. Garcia, J. A., D. Harrich, E. Soultanakis, F. Wu, R Mitsuyasu, and R. B. Gaynor. 1989. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8:765-778.
9. Hauber, J., and B. R. Cullen. 1988. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 62:673-679.
10. Heard, D. J., T. Kiss, and P. Filipowicz. 1993. Both Arabidopsis TATA binding protein (TBP) isoforms are functionally identical in RNA polymerase II and III transcription in plant cells: evidence for gene-specific changes in DNA binding specificity of TBP. EMBO J. 12:3519-3528.
11. Hernandez, N. 1985. Formation of the 3′ end of UI snRNA is directed by a conserved sequence located downstream of the coding region. EMBO J. 4:1827-1837.
12. Hernandez, N. 1993. TBP, a universal eucaryotic transcription factor? Genes Dev. 7:1291-1308.
13. Herrmann, C. H., and A. P. Rice. 1993. Specific interactions of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197:601-608.
14. Jakobovits, A., D. H. Smith, E. B. Jakobovits, and D. J. Capon. 1988. A discrete element 3′ of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV transactivator. Mol. Cell. Biol. 8:2555-2561.
15. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
16. Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (London) 330:489-493.
17. Kashanchi, F., G. Piras, M. F. Radonovich, J. F. Duvall, A. Fattaey, C.-M. Chiang, R. G. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature (London) 367:295-299.
18. Kato, H., H. Sumimoto, P. Pognonec, C.-H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655-666.
19. Keaveney, M., A. Berkenstam, M. Feigenbutz, G. Vriend, and H. G. Stunnenberg. 1993. Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells. Nature (London) 365:562-566.
20. Kelleher, R. J. I., P. M. Flanagan, D. I. Chasman, A. S. Ponticelli, K. Struhl, and R. D. Kornberg. 1992. Yeast and human TFIIDs are interchangeable for the response to acidic transcriptional activators in vitro. Genes Dev. 6:296-303.
21. Kim, J. L., D. B. Nikolov, and S. K. Burley. 1993. Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature (London) 365:520-527.
22. Kim, Y., J. H. Geiger, S. Hahn, and P. B. Sigler. 1993. Crystal structure of a yeast TBP/TATA-box complex. Nature (London) 365:512-520.
23. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
25. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
26. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1990. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev. 4:2397-2408.
27. Laspia, M. F., P. Wendel, and M. B. Mathews. 1993. HIV-1 tat overcomes inefficient transcriptional elongation in vitro. J. Mol. Biol. 232:732-746.
28. Lu, X., T. M. Welsh, and B. M. Peterlin. 1993. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J. Virol. 67:1752-1760.
29. Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990. HIV-1 Tat protein trans-activates transcription in vitro. Cell 63:791-802.
30. Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196.
31. Mermod, N., E. A. O'Neill, T. J. Kelly, and R. Tjian. 1989. The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell 58:741-753.
32. Muesing, M. A., D. H. Smith, and D. J. Capon. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48:691-701.
33. Nikolov, D. B., S.-H. Hu, J. Lin, A. Gasch, A. Hoffmann, M. Horikoshi, N.-H. Chua, R. G. Roeder, and S. K. Burley. 1992. Crystal structure of TFIID TATA-box binding protein. Nature (London) 360:40-46.
34. Niman, H. L., R. A. Houghten, L. E. Walker, R. A. Reisfeld, I. A. Wilson, J. M. Hogle, and R. A. Lerner. 1983. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc. Natl. Acad. Sci. USA 80:4949-4953.
35. Olsen, H. S., and C. A. Rosen. 1992. Contributions of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:5594-5597.
36. Ratnasabapathy, R., M. Sheldon, L. Johal, and N. Hernandez. 1990. The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev. 4:2061-2074.
37. Rittner, K., J. Churcher, M. J. Gait, and J. Karn. 1995. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J. Mol. Biol. 248: 562-580.
38. Rosen, C. A., J. G. Sodrowski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823.
39. Ruppert, S., E. H. Wang, and R. Tjian. 1993. Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation. Nature (London) 362:175-179.
40. Selby, M. J., E. S. Bain, P. A. Luciw, and B. M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558.
41. Sheldon, M., R. Ratnasabapathy, and N. Hernandez. 1993. Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol. Cell. Biol. 13:1251-1263.
42. Strubin, M., and K. Struhl. 1992. Yeast and human TFIID with altered DNA-binding specificity for TATA elements. Cell 68:721-730.
43. Subramanian, T., C. D'Sa-Eipper, B. Elangovan, and G. Chinnadurai. 1994. The activation region of the Tat protein of human immunodeficiency virus type-1 functions in yeast. Nucleic Acids Res. 22:1496-1499.
44. Tanaka, M., and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375-386.
45. Tanese, N., B. F. Pugh, and R. Tjian. 1991. Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev. 5:2212-2224.
46. Tansey, W. P., and W. Herr. 1995. The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo. Proc. Natl. Acad. Sci. USA 92:10550-10554.
47. Tansey, W. P., and W. Herr. Unpublished results.
48. Tansey, W. P., S. Ruppert, R. Tjian, and W. Herr. 1994. Multiple regions of TBP participate in the response to transcriptional activators in vivo. Genes Dev. 8:2756-2769.
49. Tjian, R., and T. Maniatis. 1994. Transcription activation: a complex puzzle with few easy pieces. Cell 77:5-8.
50. Triezenberg, S. J., R. C. Kingsbury, and S. L. McKnight. 1988. Functional dissection of VP16, the trans-activator of herpes simplex virus immediateearly gene expression. Genes Dev. 2:718-729.
51. G is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52:169-178.
52. Weinzierl, R. O. J., B. D. Dynlacht, and R. Tjian. 1993. Largest subunit of Drosophila transcription factor IID directs assembly of a complex containing TBP and a coactivator. Nature (London) 362:511-517.
53. White, J. H., C. Brou, J. Wu, N. Burton, J.-M. Egly, and P. Chambon. 1991. Evidence for a factor required for transcriptional stimulation by the chimeric acidic activator GAL-VP16 in HeLa cell extracts. Proc. Natl. Acad. Sci. USA 88:7674-7678.
54. Zhou, Q., T. G. Boyer, and A. J. Berk. 1993. Factors (TAFs) required for activated transcription interact with TATA-box binding protein conserved core domain. Genes Dev. 7:180-187.
55. Zhou, Q., and P. A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14:321-328.
56. Zoller, M., and M. Smith. 1982. Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res. 10:6487-6500.